Standard of care (SOC)
Standard of care (SOC) is a pharmaceutical drug with 163 clinical trials. Currently 52 active trials ongoing. Historical success rate of 79.7%.
Success Metrics
Based on 47 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
31
Mid Stage
34
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.2%
47 of 66 finished
28.8%
19 ended early
52
trials recruiting
163
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
HIV Engagement and Adolescent Depression Support (HEADS-UP)
Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Clinical Trials (163)
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
HIV Engagement and Adolescent Depression Support (HEADS-UP)
Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Testing the CHAT Program for Patients With Heart Failure
Community Support and Mobile Apps to Help Black Women Control High Blood Pressure After Pregnancy
PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCL
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Pix-Risk: Early Detection of Rheumatoid Arthritis Via the DETECTRA Platform
Appendectomy as an Adjunct Procedure in Endometriosis Surgery
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness
A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression
Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes
A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
EASE: The Materna Prep Pivotal Study
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 163